Fact CheckerSign in

NCT06247033Completed

Evaluation of the Efficacy of Transcutaneous Tibial Nerve Stimulation on Post-Stroke Overactive Bladder

Source: ClinicalTrials.gov · Last updated 14 May 2025

Brief summary (registry, in English)

The goal of this clinical trial is to comparing the efficacies of different managements in patients with overactive bladder symptoms with stroke The main question it aims to answer are: * Are pelvic floor training exercises and bladder training enough to ease the symptoms of overactive bladder in patients with stroke? * Is tibial nerve stimulation really effective and does it decrease the need of medications in patients with overactive bladder with stroke? Participants are questioned if they have the symptoms of overactive bladder. After urodynamic evaluation, they are separated in 2 groups. Pelvic floor training exercises and bladder training are given in both groups; while one of the groups is followed with tibial nerve stimulation and the other one is followed with sham tibial nerve stimulation for 6 weeks. Our main aim was to compare effectiveness of tibial nerve stimulation in patiens with overactive bladder with stroke.

Status (registry)
Completed
Study type
Interventional
Enrollment
28 (actual)
First submitted
21 Jan 2024
Start date
1 Jan 2024
Primary completion date
1 Jan 2025
Lead sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Diseases
Stroke
NCT number
NCT06247033

What you commit to

  • Study type: Interventional
  • Participants enrolled: 28
  • From 1 Jan 2024 to the primary completion date, 1 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Already receiving any treatment because of neurogenic bladder

Other illness

  • Psychiatric or cognitive impairment, MMT \< 18
  • Urinary symptoms before stroke
  • Cardiac pacemaker
  • Urinary tract infection
  • History of botulinum toxin injection to the detrusor muscle
  • Active malignancy

Other

  • Patients who not willing to be a participant
  • Spasticity that effects whole body, MAS 3 and above
  • Global or sensorial aphasia
  • Benign prostate hypertrophy
  • Pregnants
  • Post-void residue above 200 mL

Who the study is looking for

  • Stroke patients who applied to our hospital with the illness interval of 6 months-24 months
  • Cooperated patients with mini mental test 18 and above
  • Patients who willing to be a participant
  • Patients with scoring of OABSS 3 and above (at least 2 points must be gained from question 3.) will be evaluated with urodynamic study and only the patients with overactive detrusor findings during urodynamic study will be included.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gaziler PMR, Training and Research Hospital, Department of PMR
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.